Zhi Dong Jiang

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea
    Zhi Dong Jiang
    Center for Infectious Diseases, 1200 Herman Pressler, Room 739, University of Texas School of Public Health, Houston, Texas 77030, USA
    Clin Gastroenterol Hepatol 5:964-8. 2007
  2. ncbi Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone
    Herbert L DuPont
    Center for Infectious Diseases, University of Texas School of Public Health, Houston, Texas, USA
    Clin Gastroenterol Hepatol 5:451-6. 2007
  3. ncbi Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries
    Jamal A Mohamed
    Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School, Houston, TX 77030, USA
    J Clin Microbiol 45:121-6. 2007
  4. ncbi Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico
    Hoonmo L Koo
    Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Clin Microbiol 48:1673-6. 2010
  5. ncbi A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North Ame
    Jamal A Mohamed
    Division of Infectious Diseases, The University of Texas Medical School, Center for Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
    J Infect Dis 199:477-85. 2009
  6. ncbi Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico
    Jose Flores
    Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA
    J Travel Med 15:156-61. 2008
  7. ncbi Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers
    Zhi Dong Jiang
    The University of Texas Health Science Center School of Public Health, Houston, Texas 77030, USA
    J Clin Microbiol 40:4185-90. 2002
  8. ncbi Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region
    Zhi Dong Jiang
    University of Texas School of Public Health, Houston, Texas, USA
    J Infect Dis 188:506-11. 2003
  9. ncbi A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
    Herbert L DuPont
    University of Texas Houston, Baylor College of Medicine, St Luke s Episcopal Hospital, and M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Intern Med 142:805-12. 2005
  10. ncbi PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea
    Kevin A Grimes
    Division of Infectious Diseases, The University of Texas Medical School, Houston, Texas, USA
    J Clin Microbiol 46:2227-30. 2008

Collaborators

Detail Information

Publications56

  1. ncbi Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea
    Zhi Dong Jiang
    Center for Infectious Diseases, 1200 Herman Pressler, Room 739, University of Texas School of Public Health, Houston, Texas 77030, USA
    Clin Gastroenterol Hepatol 5:964-8. 2007
    ..This study examined the relationship between serum immunoglobulin G antibodies to CD toxin A and the presence of IL-8 AA genotype in hospitalized patients with CDAD...
  2. ncbi Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone
    Herbert L DuPont
    Center for Infectious Diseases, University of Texas School of Public Health, Houston, Texas, USA
    Clin Gastroenterol Hepatol 5:451-6. 2007
    ..This study evaluated the efficacy and safety of rifaximin-loperamide in the treatment of travelers' diarrhea...
  3. ncbi Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries
    Jamal A Mohamed
    Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School, Houston, TX 77030, USA
    J Clin Microbiol 45:121-6. 2007
    ..This study suggests that biofilm formation is a common phenomenon among EAEC isolates derived from travelers with or without diarrhea and that multiple genes associated with biofilm formation are regulated by aggR...
  4. ncbi Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico
    Hoonmo L Koo
    Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Clin Microbiol 48:1673-6. 2010
    ..Significant variation in the prevalence of NoV diarrhea and in the predominant genogroup infecting travelers was demonstrated, dependent upon the specific geographic location and over time...
  5. ncbi A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North Ame
    Jamal A Mohamed
    Division of Infectious Diseases, The University of Texas Medical School, Center for Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
    J Infect Dis 199:477-85. 2009
    ....
  6. ncbi Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico
    Jose Flores
    Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA
    J Travel Med 15:156-61. 2008
    ..However, the role of LT-producing ETEC (LT-ETEC) as a cause of diarrhea is controversial. We conducted a cohort study in US students traveling to Mexico to assess the ETEC-LT seroconversion rate after natural exposure...
  7. ncbi Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers
    Zhi Dong Jiang
    The University of Texas Health Science Center School of Public Health, Houston, Texas 77030, USA
    J Clin Microbiol 40:4185-90. 2002
    ..The different patterns of virulence factors of EAEC revealed several clusters demonstrating diversity among the isolates from the various regions...
  8. ncbi Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region
    Zhi Dong Jiang
    University of Texas School of Public Health, Houston, Texas, USA
    J Infect Dis 188:506-11. 2003
    ..0053). In the present study, the AA genotype at the -251 position was associated with the occurrence of EAEC-associated diarrhea and increased levels of fecal IL-8...
  9. ncbi A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
    Herbert L DuPont
    University of Texas Houston, Baylor College of Medicine, St Luke s Episcopal Hospital, and M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Intern Med 142:805-12. 2005
    ..Travelers' diarrhea causes substantial morbidity and postinfectious irritable bowel syndrome...
  10. ncbi PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea
    Kevin A Grimes
    Division of Infectious Diseases, The University of Texas Medical School, Houston, Texas, USA
    J Clin Microbiol 46:2227-30. 2008
    ..DNA extracted from fecal cards that was used for the detection of occult blood is of use in identifying diarrheagenic E. coli...
  11. ncbi Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico
    Jamal A Mohamed
    Department of Internal Medicine, Division of Infectious Diseases University of Texas Medical School at Houston, Houston, TX 77030, USA
    Clin Infect Dis 52:1332-41. 2011
    ....
  12. ncbi Epidemiology of cryptosporidiosis in North American travelers to Mexico
    Parvathy Nair
    The University of Texas Health Science Center at Houston Medical School and School of Public Health, Houston, Texas, USA
    Am J Trop Med Hyg 79:210-4. 2008
    ..Speciation by 18SrRNA sequencing showed that 13 cases were caused by C. parvum and only 1 case was caused by C. hominis. ELISA showed a sensitivity of 50% and specificity of 100% compared with PCR...
  13. ncbi Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico
    Nicolas A Villa
    Baylor College of Medicine, Houston, TX, USA
    J Travel Med 18:56-8. 2011
    ..Serum IgG, IgA, and IgM antibodies to Campylobacter seroconverted in only 2 of 353 participants (0.6%). These data further support that C jejuni infection is an unusual cause of travelers' diarrhea in US visitors to Mexico...
  14. ncbi A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
    Kevin W Garey
    University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030, USA
    J Antimicrob Chemother 66:2850-5. 2011
    ..15). Conclusions Patients with CDI given a rifaximin chaser regimen experienced a decreased incidence of recurrent diarrhoea compared with placebo...
  15. ncbi Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin
    Herbert L DuPont
    Houston School of Public Health, Houston, TX, USA
    Clin Infect Dis 41:S571-6. 2005
    ....
  16. ncbi Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries
    David B Huang
    Baylor College of Medicine, Division of Infectious Diseases, Houston, TX, USA
    J Med Microbiol 56:1386-92. 2007
    ....
  17. ncbi Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study
    Ismail M Meraz
    School of Public Health, University of Texas, Houston, TX 77030, USA
    J Travel Med 15:412-8. 2008
    ..Enteropathogens cannot be identified in 40% to 50% of subjects with travelers' diarrhea (TD)...
  18. ncbi Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to Mexico
    David B Huang
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Trop Med Hyg 69:506-8. 2003
    ..Our study suggests that clinical illness by EAEC is not explained by presence of a defined EAEC virulence factors, and we provide suggestive evidence that EAEC infection protects against future symptomatic infection...
  19. ncbi Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei
    Zhi Dong Jiang
    Center for Infectious Diseases, The University of Texas School of Public Health, 1200 Herman Pressler, Room 706, Houston, TX 77030, USA
    Int J Antimicrob Agents 35:278-81. 2010
    ..At subinhibitory concentrations, rifaximin alters the virulence of ETEC, EAEC and S. sonnei isolates. These findings help explain the efficacy of rifaximin despite minimal alteration of colonic flora...
  20. ncbi A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season
    Jose Flores
    Center for Infectious Diseases, School of Public Health, The University of Texas Health Science Center at Houston, TX, USA
    J Travel Med 18:333-6. 2011
    ..Rifaximin has been shown to be effective in treating and preventing travelers' diarrhea (TD) during the summer season...
  21. ncbi In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008
    Jeannette Ouyang-Latimer
    Baylor College of Medicine, Houston, Texas, USA
    Antimicrob Agents Chemother 55:874-8. 2011
    ..There were no significant changes in rifaximin MICs. Rising MICs over time imply the need for continuous surveillance of susceptibility patterns worldwide and geographically specific recommendations in TD therapy...
  22. ncbi Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance
    Dhara Shah
    University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030, USA
    Expert Rev Anti Infect Ther 8:555-64. 2010
    ..This review will focus primarily on scientific studies published in the last 36 months in order to provide an up-to-date review on the topic...
  23. ncbi Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, and St Luke s Episcopal Hospital, Houston, TX 77030, USA
    J Travel Med 14:312-9. 2007
    ....
  24. ncbi Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
    Zhi Dong Jiang
    Center for Infectious Diseases, University of Texas Houston School of Public Health, Houston, TX 77030, USA
    J Infect Dis 185:497-502. 2002
    ..Quinolones were active against the bacterial enteropathogens in the 3 sites...
  25. ncbi A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico
    Jamal A Mohamed
    Division of Infectious Diseases, The University of Texas Medical School, Houston, TX 77030, USA
    Clin Infect Dis 44:945-52. 2007
    ..We investigated the impact that selected single-nucleotide polymorphisms (SNPs) in the human lactoferrin gene have on susceptibility to traveler's diarrhea...
  26. ncbi Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested
    Thushara Galbadage
    The University of Texas School of Public Health at Houston, Houston, TX 77225, USA
    Am J Trop Med Hyg 80:20-3. 2009
    ..0%), 37 (31.9%), 45 (38.8%) and 46 (39.7%), respectively. Based on our results, we recommend the testing of at least 10 E. coli colonies for optimum detection of ETEC in patients with TD...
  27. ncbi Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico
    Javier A Adachi
    Center for Infectious Diseases, Medical School and School of Public Health, University of Texas-Houston, Houston, TX, USA
    J Infect Dis 185:1681-3. 2002
    ..Symptomatic EAEC infection occurred early after arrival in Guadalajara, Mexico, and was as common as ETEC infection. Asymptomatic EAEC infection was recurrent...
  28. ncbi New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control
    Herbert L DuPont
    The University of Texas School of Public Health, Houston, Texas 77030, USA
    Curr Opin Infect Dis 21:500-7. 2008
    ..The present review focuses on scientific papers published in the past 18 months in an attempt to provide the latest information on the topic...
  29. ncbi Rifaximin treatment of pathogen-negative travelers' diarrhea
    Herbert L DuPont
    Center for Infectious Diseases, Houston School of Public Health, The University of Texas, Houston, TX, USA
    J Travel Med 14:16-9. 2007
    ..Antibacterial drugs appear to be effective in shortening the illness of a majority of cases of travelers' diarrhea...
  30. ncbi A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection
    Kevin W Garey
    University of Houston College of Pharmacy, Houston, Texas, USA
    Clin Infect Dis 51:1406-10. 2010
    ..We hypothesized that a common single-nucleotide polymorphism (SNP) in the -251 region of the IL-8 gene promoter may be predictive of recurrent CDI...
  31. ncbi Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas
    Hoonmo L Koo
    Baylor College of Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA
    Clin Infect Dis 47:218-21. 2008
    ..Prevention of traveler's diarrhea by avoidance of "high-risk" foods may be unsuccessful, because contamination of foods may occur regardless of how they are prepared...
  32. ncbi Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages
    Sue M Turner
    Division of Immunity and Infection, The Medical School, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom, and St. Luke's Episcopal Hospital, Houston, TX 77083, USA
    J Clin Microbiol 44:4528-36. 2006
    ..coli revealed that they were not abundant. These observations have significant implications for disease epidemiology and for the design of effective vaccines...
  33. ncbi Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico
    Pablo C Okhuysen
    Division of Infectious Diseases, Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin, JFB 1.728, Houston, TX 77096, USA
    Am J Gastroenterol 99:1774-8. 2004
    ..Postinfectious complications of traveler's diarrhea require further study for etiology and strategy for prevention...
  34. ncbi Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species
    Zhi Dong Jiang
    Center for Infectious Diseases, University of Texas School of Public Health, 1200 Herman Pressler Room 741, Houston, TX 77030, USA
    J Clin Microbiol 48:1417-9. 2010
    ..S. and European travelers with acute diarrhea acquired in Mexico, Guatemala, and India. Arcobacter butzleri and ETBF were detected in 8% and 7% of diarrhea cases, respectively...
  35. ncbi Peripartum Clostridium difficile infection: case series and review of the literature
    Kevin W Garey
    Texas Medical Center, University of Houston College of Pharmacy, Houston, TX 77030, USA
    Am J Obstet Gynecol 199:332-7. 2008
    ..Further research into the scope and risk factors for peripartum CDI is warranted...
  36. ncbi Travel and travelers' diarrhea in patients with irritable bowel syndrome
    Herbert L DuPont
    University of Texas School of Public Health, Houston, TX, USA
    Am J Trop Med Hyg 82:301-5. 2010
    ..Symptoms of established functional bowel disorder in each clinical category were shown to worsen after travel-related acute diarrhea...
  37. ncbi Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity
    David E Greenberg
    Baylor College of Medicine, Houston, Texas, USA
    J Infect Dis 185:944-9. 2002
    ..Bacterial pathogens causing traveler's diarrhea commonly produce intestinal inflammation, although a subset of patients with EAEC-associated diarrhea fail to develop an inflammatory response...
  38. ncbi Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico
    Javier A Adachi
    Center for Infectious Diseases, University of Texas-Houston School of Public Health and Medical School, Houston, Texas, USA
    Clin Infect Dis 37:1165-71. 2003
    ..Azithromycin was found to be a safe and effective alternative to levofloxacin for the treatment of acute travelers' diarrhea in US adult travelers to Mexico...
  39. ncbi Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli
    David B Huang
    University of Texas Health Science Center, Houston Medical School, 6431 Fannin, JFB 1.728, Houston, TX 77030, USA
    Clin Diagn Lab Immunol 11:548-51. 2004
    ....
  40. ncbi Bile acids improve the antimicrobial effect of rifaximin
    Charles Darkoh
    University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA
    Antimicrob Agents Chemother 54:3618-24. 2010
    ..The water insolubility of rifaximin is the likely explanation for the drug's minimal effects on colonic flora and fecal pathogens, despite in vitro susceptibility...
  41. ncbi Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital
    Miguel Salazar
    St Luke s Episcopal Hospital, Houston, TX 77030, USA
    Pharm World Sci 31:565-71. 2009
    ..To assess changes in testing and treatment trends of CDI at a time when the Clostridium difficile hypervirulent strain was first identified...
  42. ncbi Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles
    Eric L Brown
    The University of Texas School of Public Health, 1200 Herman Pressler, Houston, TX 77030, USA
    Antimicrob Agents Chemother 54:388-96. 2010
    ..The study provides evidence that rifaximin-mediated changes in epithelial cell physiology are associated with changes in bacterial attachment/internalization and reduced inflammatory cytokine release...
  43. ncbi Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy
    Rosa M Infante
    Center for Infectious Diseases, The University of Texas-Houston School of Public Health and Medical School, Houston, Texas, USA
    Clin Gastroenterol Hepatol 2:135-8. 2004
    ..The study provides information on the value of the poorly absorbed drug rifaximin in therapy of travelers' diarrhea...
  44. ncbi Enteroaggregative Escherichia coli: an emerging enteric pathogen
    David B Huang
    Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    Am J Gastroenterol 99:383-9. 2004
    ..The objective of this review is to increase awareness of this important emerging pathogen and to discuss the epidemiology, pathogenesis, and host-pathogen factors associated with EAEC infection...
  45. ncbi Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas
    Javier A Adachi
    University of Texas, St. Luke's Episcopal Hospital, and Baylor College of Medicine, Houston, Texas 77030, USA
    Ann Intern Med 136:884-7. 2002
    ..coli and 14 of 32 contained enteroaggregative E. coli. CONCLUSIONS: Contamination with E. coli was common in samples of Mexican tabletop sauces from Guadalajara restaurants. These sauces commonly contained enteric pathogens...
  46. ncbi United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts
    David B Huang
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Travel Med 11:143-5. 2004
    ..Nondrinkers also deserve further study in larger numbers to confirm an apparently high attack rate of diarrhea and to explore what risk factors might be involved...
  47. ncbi Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico
    Alain R Bouckenooghe
    Veterans Affairs Medical Center, Baylor College of Medicine, and University of Texas Medical School and School of Public Health, Houston, Texas, USA
    J Travel Med 9:137-40. 2002
    ..0004), as was the average number of unformed stools passed over 4 days (Mexicans 8.8 versus travelers 17.9 stools; p =.0009..
  48. ncbi A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection
    Hoonmo L Koo
    Baylor College of Medicine, University of Texas Houston School of Public Health, Houston, Texas, USA
    Clin Infect Dis 48:e75-7. 2009
    ..We describe here the unique challenges of the identification of NoVs as the true etiologic pathogen in an outbreak occurring in a health care setting, where C. difficile infection is endemic, as well as the important lessons learned...
  49. ncbi Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells
    Mohamad S Miqdady
    Baylor College of Medicine, Houston, Texas, USA
    J Clin Microbiol 40:3066-7. 2002
    ..Using formalin-fixed HEp-2 cells will improve the efficiency of EAEC identification...
  50. ncbi Clostridium difficile infection in patients with ileal pouch-anal anastomosis
    B O Shen
    Center for Inflammatory Bowel Disease, Department of Gastroenterology Hepatology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Clin Gastroenterol Hepatol 6:782-8. 2008
    ..S. The importance of C difficile infection in patients with ileal pouch-anal anastomosis (IPAA) is unknown. This study was designed to determine risk of acquiring C difficile infection in pouch disorders...
  51. ncbi Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
    Sarah A Frech
    IOMAI Corporation, Gaithersburg, MD, USA
    Lancet 371:2019-25. 2008
    ..We investigated the rate of diarrhoea attacks, safety, and feasibility of a vaccine containing heat-labile enterotoxin (LT) from ETEC delivered to the skin by patch in travellers to Mexico and Guatemala...
  52. ncbi Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico
    Gwangpyo Ko
    Department of Environmental Health, School of Public Health, Seoul National University, 28 Yunkeun dong, ChongRo Ku, Seoul 110 799, South Korea
    J Clin Microbiol 43:6126-9. 2005
    ..This study indicates that NoV is an underappreciated cause of traveler's diarrhea...
  53. ncbi A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea
    David N Taylor
    Salix Pharmaceuticals, Inc, Morrisville, North Carolina, USA
    Am J Trop Med Hyg 74:1060-6. 2006
    ..35 versus rifaximin). Rifaximin was less effective than ciprofloxacin for invasive intestinal bacterial pathogens. Oral rifaximin is a safe and effective treatment of travelers' diarrhea caused by noninvasive pathogens...
  54. ncbi A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea
    Zhi Dong Jiang
    The University of Texas School of Public Health, USA
    Am J Gastroenterol 101:1112-6. 2006
    ..We hypothesized that like other inflammatory mucosal infections, susceptibility to CDD would relate to genetically determined variations in the production of IL-8...
  55. ncbi Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses
    Gwangpyo Ko
    Seoul National University, School of Public Health, Institute of Health and Environment, Seoul, Korea
    J Med Virol 78:825-8. 2006
    ..Intestinal inflammation associated with increased fecal lactoferrin, important in bacterial enteric infection, was not found in NoV-associated gastroenteritis...
  56. ncbi Identification of compounds that inhibit late steps of peptidoglycan synthesis in bacteria
    Maureen DeCenzo
    Millennium Pharmaceuticals, Inc, Cambridge, MA, USA
    J Antibiot (Tokyo) 55:288-95. 2002
    ..This screening system proved to be especially useful because it was sufficiently sensitive and robust to detect inhibitors among samples of crude preparations or varying states of purity...